{"id":"W4392768049","doi":"10.1136/rmdopen-2023-003839","title":"Impact of filgotinib on pain control in the phase 3 FINCH studies","year":2024,"lang":"en","type":"article","venue":"RMD Open","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University","funders":"UCB Pharma; Medac; Nordic Pharma Group; Swedish Orphan Biovitrum; Biogen; Celgene; Gilead Sciences; Celltrion; Sanofi; Galápagos; Amgen; Pfizer; Eli Lilly and Company; Mylan; GlaxoSmithKline","keywords":"Medicine; Adalimumab; Visual analogue scale; Placebo; Internal medicine; Rheumatoid arthritis; Methotrexate; Pain assessment; Physical therapy; Pain management; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01770519,0.001152514,0.00245205,0.0006410595,0.000556394,0.001772187,0.0008500447,0.0008895196,0.005268648],"category_scores_gemma":[0.009108119,0.0002674326,0.005947073,0.0009260424,0.0005816888,0.0008820792,0.0007815575,0.00168004,0.000335381],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001451347,"about_ca_system_score_gemma":0.002604021,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0021864,"about_ca_topic_score_gemma":0.01110833,"domain_scores_codex":[0.9922558,0.005162799,0.0004487133,0.0005288823,0.0008271293,0.0007766931],"domain_scores_gemma":[0.9929307,0.003817148,0.001868469,0.000430928,0.0006468474,0.0003059806],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7137353,0.00283549,0.0286633,0.01093843,0.04354454,0.0002403432,0.0003678136,0.003396712,0.008952338,0.0006616687,0.01058839,0.1760757],"study_design_scores_gemma":[0.2751517,0.2926158,0.2938659,0.003203617,0.0767873,0.0008591763,0.0004626452,0.00290601,0.01216879,0.001800115,0.03992109,0.0002579668],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9077743,0.05548101,0.001766975,0.001665028,0.0004491287,0.005404065,0.01199674,0.0002505078,0.01521234],"genre_scores_gemma":[0.9867019,0.003829835,0.001213156,0.001195527,0.0001765958,0.002079457,0.002950479,0.00006035747,0.001792719],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01770519,"threshold_uncertainty_score":0.09363508,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07273180412453929,"score_gpt":0.4782001916973652,"score_spread":0.4054683875728259,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}